Resurrect Bio restores latent disease-resistance genes in crops to reduce losses from pathogens. It works with seed companies and growers of high-value crops.
Reactivating dormant plant immunity to create disease-resistant crops
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€8,800,000
Total raised
-
Valuation
20
Employees
2022
Founded
Latest round
Series A - May 1, 2026
Series A - €8,800,000
May 1, 2026
Open roles
Resurrect Bio is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile